Long-term outcome and toxicity of hypofractionated stereotactic body radiotherapy as a boost treatment for head and neck cancer: the importance of boost volume assessment.

Radiat Oncol · 2012 · PMC3412714 · PMID 22691266

Europe PMC DOI

hedged sentence

0.0580

closest p · 1.2× alpha

0.0580

boldest claim

The sentences

marginally significantp = 0.058so close (0.05 < p ≤ 0.1)

Among the variables, a large GTV in SBRT was only significantly associated with late toxicities (p = 0.038), and SBRT fractional dose was also a marginally significant factor (p = 0.058) (Table 4 ).

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.